Table 1.
Antibody profiles of dengue-suspected patients and apparently healthy persons in Myanmar, 2004–2017
| Sample collection year | Number of tested samples | ZIKV IgM positive (%) | DENV IgM positive (%) | ZIKV IgM positive (%) but DENV IgM negative | DENV IgM positive (%) but ZIKV IgM negative | ZIKV and DENV IgM positive (%) | Flavi IgG positive (%) |
|---|---|---|---|---|---|---|---|
| Dengue suspected patients (symptomatic) | |||||||
| 2004–2006 | 45 | 13 (28.8) | 15 (33.3) | 2 (4.4) | 4 (8.8) | 11 (24.4) | 28 (62.2) |
| 2008–2010 | 134 | 15 (11.1) | 25 (18.6) | 9 (6.7) | 19 (14.1) | 6 (4.4) | 43 (32) |
| 2013 | 123 | 22 (17.8) | 42 (34.1) | 12 (9.7) | 32 (26.0) | 10 (8.1) | 26 (22.7) |
| 2015 | 79 | 27 (34.1) | 35 (44.3) | 7 (8.8) | 15 (18.9) | 20 (25.3) | 23 (29.1) |
| Total | 381 | 77 (20.2) | 117 (30.7) | 30 (7.9) | 70 (18.4) | 47 (12.3) | 120 (31.5) |
| Apparently healthy persons (asymptomatic) | |||||||
| 2017 | 81 | 8 (9.8) | 3 (3.7) | 6 (7.4) | 1 (1.2) | 2 (2.4) | 78 (96.2) |
DENV = dengue virus; IgG = immunoglobulin G; IgM = immunoglobulin M; ZIKV = Zika virus.